Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SMS Lifesciences India Ltd. ( (IN:SMSLIFE) ) has provided an announcement.
SMS Lifesciences India Ltd. has announced the record date for its 2024-25 dividend as September 24, 2025, with the dividend payment subject to shareholder approval at the upcoming AGM on September 30, 2025. Additionally, the company has launched the ‘Saksham Niveshak’ campaign to engage shareholders in updating KYC details and claiming unclaimed dividends, aligning with regulatory compliance and investor empowerment initiatives.
More about SMS Lifesciences India Ltd.
SMS Lifesciences India Ltd. operates in the pharmaceutical industry, focusing on the production and supply of active pharmaceutical ingredients (APIs) and intermediates. The company is dedicated to providing high-quality products and services to its clients, with a strong emphasis on compliance and innovation.
Average Trading Volume: 459
Technical Sentiment Signal: Buy
Current Market Cap: 3.35B INR
Find detailed analytics on SMSLIFE stock on TipRanks’ Stock Analysis page.